Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (21467)	5/28/1998 12:53:00 AM
From: Henry Niman	Respond to of 32384

I think that LGND will get an expedited review and approval should come sometime in 4Q. This one is clearly in the slam dunk category.

To: Flagrante Delictu who wrote (21467)	5/28/1998 8:01:00 AM
From: tonyt	Read Replies (1) \| Respond to of 32384

>But this one seems to be a layup. If Ligand can easily miss a 'slam dunk', I'm not so sure that they'll make the layup. Todays activity should be uneventful as this 'news' is so widely known that it's irrelevant. --Tony

To: Flagrante Delictu who wrote (21467)	5/28/1998 8:37:00 AM
From: Machaon	Respond to of 32384

<< But this one seems to be a layup. >> LGND seems to have strong test results. Even if we only see a move back to a little above $14 today, it is nice to know that our investments are in a company that can provide relief to victims of KS. Imagine having many cancer sores on your body. My congratulations to LGND, for this first breakthru, in a topical treatment for skin cancer. Let's hope that this is the first of many successful innovations, by LGND, against cancer and other major diseases. Now we go into a wait state, waiting for the FDA to make a decision. Ligand has said that they held up the NDA in order to put forth a stronger case for approval, and implied that they could get faster approval. It makes sense to me. And, the FDA could substantiate it's new resolve to speed up the approval process. A lot going on in the NDA and clinical area, in the near future. Should be a very exciting and interesting time for LGND share holders. Good luck, Bob